Dexmedetomidine Hydrochloride — Veterinary Vademecum Drug Reference

Dosage & Administration Guidelines

Species	Route	Dose	Frequency	Duration & Clinical Notes
Dog	IV	0.5-2 mcg/kg (for sedation/analgesia)	Single dose; may repeat at 30-60 min if needed	Duration: 30-60 minutes Notes: For premedication, use 1-2 mcg/kg IV or 2-5 mcg/kg IM. Higher doses (up to 10 mcg/kg) may be used for profound sedation but increase risk of bradycardia and hypotension.
Dog	IM	2-5 mcg/kg	Single dose	Duration: 30-60 minutes Notes: Onset of sedation within 10-15 minutes. May be combined with opioids (e.g., butorphanol) for enhanced analgesia.
Cat	IV	0.5-1.5 mcg/kg	Single dose	Duration: 30-60 minutes Notes: For sedation and analgesia. Use lower doses in geriatric or debilitated cats.
Cat	IM	2-5 mcg/kg	Single dose	Duration: 30-60 minutes Notes: Commonly used for chemical restraint. May be combined with ketamine for short procedures.
Horse	IV	0.5-1 mcg/kg	Single dose	Duration: 30-60 minutes Notes: For standing sedation. Administer slowly to avoid ataxia. May be combined with opioids for analgesia.
Horse	IM	1-2 mcg/kg	Single dose	Duration: 30-60 minutes Notes: Onset slower than IV. Use caution in horses with cardiovascular disease.
Cattle	IV	0.5-1 mcg/kg	Single dose	Duration: 30-60 minutes Notes: For sedation and analgesia. May cause ruminal stasis; monitor for bloat.
Cattle	IM	1-2 mcg/kg	Single dose	Duration: 30-60 minutes Notes: For chemical restraint. Use with caution in pregnant animals.
Small Ruminants (sheep, goats)	IV	0.5-1 mcg/kg	Single dose	Duration: 30-60 minutes Notes: For sedation and analgesia. Monitor for respiratory depression.
Small Ruminants (sheep, goats)	IM	1-2 mcg/kg	Single dose	Duration: 30-60 minutes Notes: For chemical restraint. May be combined with ketamine.
Rabbit	IV	0.05-0.1 mg/kg (50-100 mcg/kg)	Single dose	Duration: 30-60 minutes Notes: For sedation and analgesia. Use lower doses in debilitated animals.
Rabbit	IM	0.1-0.2 mg/kg (100-200 mcg/kg)	Single dose	Duration: 30-60 minutes Notes: Commonly used for premedication. May cause bradycardia; monitor heart rate.
Bird/Poultry	IM	0.05-0.1 mg/kg (50-100 mcg/kg)	Single dose	Duration: 30-60 minutes Notes: For sedation and restraint. Use with caution; birds are sensitive to alpha-2 agonists.
Exotic/Other (e.g., reptiles)	IM	0.05-0.1 mg/kg (50-100 mcg/kg)	Single dose	Duration: Variable Notes: Dose varies widely by species; consult specialized references.

Clinical Indications & Species Uses

General Indications

Sedation
Analgesia
Preanesthetic medication
Anesthetic adjunct

Dog (Canine)

Sedation
Analgesia
Preanesthetic medication
Anesthetic adjunct (reduces inhalant requirements)
Chemical restraint for minor procedures

Cat (Feline)

Sedation
Analgesia
Preanesthetic medication
Anesthetic adjunct
Chemical restraint

Horse (Equine)

Sedation
Analgesia
Preanesthetic medication
Standing chemical restraint for minor procedures

Cattle (Bovine)

Sedation
Analgesia
Preanesthetic medication
Chemical restraint

Small Ruminants (Sheep / Goat)

Sedation
Analgesia
Preanesthetic medication

Rabbit & Small Mammals

Sedation
Analgesia
Preanesthetic medication

Avian & Poultry

Sedation
Analgesia
Preanesthetic medication (limited use)

Exotic & Other Species

Sedation and analgesia in various exotic species (e.g., reptiles, small mammals) with careful dosing

Pharmacology & Mechanism of Action

Drug Class: Alpha-2 Adrenergic Agonist | Pharmacological Group: Sedative, Analgesic, Anesthetic Adjunct

Mechanism of Action: Dexmedetomidine is a highly selective alpha-2 adrenergic agonist. It produces sedation, analgesia, and muscle relaxation by binding to alpha-2 adrenergic receptors in the central nervous system (locus coeruleus) and spinal cord. Activation of these receptors decreases sympathetic outflow, reduces norepinephrine release, and inhibits pain transmission. The sedative effect is mediated by hyperpolarization of neurons in the locus coeruleus, while analgesia results from action at both supraspinal and spinal sites. It also has peripheral effects including vasoconstriction and bradycardia.

Pharmacodynamics: Dexmedetomidine produces dose-dependent sedation, analgesia, and anxiolysis. It reduces the minimum alveolar concentration (MAC) of inhalant anesthetics by up to 50%. It causes an initial transient increase in systemic vascular resistance and blood pressure followed by a decrease in heart rate and cardiac output. It also reduces gastrointestinal motility and has antiemetic properties. The duration of action is dose-dependent, typically 30-60 minutes for sedation, but can be prolonged with higher doses.

⚡ Pharmacokinetics Summary

Absorption: After intramuscular (IM) or subcutaneous (SC) administration, dexmedetomidine is rapidly and well absorbed. Peak plasma concentrations occur within 15-30 minutes after IM injection. Oral bioavailability is low due to extensive first-pass metabolism.

Distribution: Dexmedetomidine is widely distributed throughout the body. It crosses the blood-brain barrier and placenta. The volume of distribution is large, approximately 1.5-3 L/kg in dogs. It is approximately 94% protein-bound in dogs.

Metabolism: Dexmedetomidine is extensively metabolized in the liver via glucuronidation and hydroxylation, primarily by cytochrome P450 enzymes (CYP2A6 in humans, but species-specific). Metabolites are inactive.

Excretion: Metabolites are excreted primarily in the urine (about 95%) and feces (about 5%). In dogs, the elimination half-life is approximately 1-2 hours, but the pharmacodynamic effects may last longer.

Half-Life: Dogs: 1-2 hours; Cats: 1-2 hours; Horses: 1-2 hours; Cattle: 1-2 hours (approximate)

Bioavailability: IM: ~80% in dogs; SC: ~70% in cats; Oral: <20% due to first-pass metabolism

Protein Binding: Approximately 94% in dogs, 92% in cats

Available Formulations & Strengths

Injectable Solution 0.1 mg/mL (100 mcg/mL), 0.5 mg/mL (500 mcg/mL) (IV, IM, SC)

Oral Gel (for dogs, not commonly used) 0.1 mg/mL (Oral)

Contraindications & Clinical Warnings

Contraindications:

Hypersensitivity to dexmedetomidine or other alpha-2 agonists
Severe cardiovascular disease (e.g., heart block, severe hypotension, hypovolemia)
Advanced hepatic or renal disease
Shock or severely debilitated animals
Animals with respiratory distress or compromised ventilation
Use in animals with a history of seizures (may lower seizure threshold)
Pregnancy (unless benefit outweighs risk; may cause uterine contractions)

Warnings & Clinical Precautions:

Use with caution in geriatric, pediatric, or debilitated animals
Monitor heart rate, blood pressure, and respiratory rate during use
May cause bradycardia, hypotension, and decreased cardiac output; have atipamezole (alpha-2 antagonist) available for reversal
In horses, avoid rapid IV administration to prevent ataxia and collapse
In ruminants, monitor for bloat due to decreased gastrointestinal motility
Use with caution in animals with pre-existing renal or hepatic impairment
May cause hyperglycemia; monitor blood glucose in diabetic animals
Avoid use in animals with a history of seizures
Do not use in animals with known hypersensitivity to alpha-2 agonists
In food animals, observe withdrawal times

Adverse Effects & Reactions

Common:

Bradycardia
Hypotension
Sedation
Ataxia
Vomiting (especially in cats)
Dry mouth
Hypothermia
Decreased gastrointestinal motility

Serious / Severe:

Severe bradycardia or heart block
Severe hypotension or hypertension (transient)
Respiratory depression
Pulmonary edema (rare)
Cardiac arrest (overdose)
Hyperglycemia

Rare:

Seizures
Arrhythmias
Prolonged sedation
Local tissue necrosis at injection site (if extravasation)

Key Drug Interactions

Interacting Drug / Class	Clinical Effect & Mechanism	Severity
Other central nervous system depressants (e.g., barbiturates, inhalant anesthetics, opioids)	Additive sedation, respiratory depression, and hypotension; reduce doses of both agents	High
Anticholinergics (e.g., atropine, glycopyrrolate)	May reduce bradycardia but can cause hypertension and tachycardia; use with caution	Moderate
Beta-blockers (e.g., propranolol)	May potentiate bradycardia and negative inotropic effects	Moderate
Ketamine	May cause profound sedation and cardiovascular effects; often used in combination for anesthesia, but monitor closely	Moderate
Atipamezole (alpha-2 antagonist)	Reverses effects of dexmedetomidine; use for overdose or to shorten recovery	High
Diuretics	May increase risk of hypotension due to volume depletion	Moderate

Overdose & Toxicity Management

Signs of Toxicity:

Severe bradycardia
Hypotension
Respiratory depression
Coma
Cardiac arrhythmias
Hypothermia
Pulmonary edema (rare)

Emergency Treatment Protocol: Administer atipamezole (alpha-2 antagonist) at a dose of 0.05-0.1 mg/kg IV or IM (5-10 times the dexmedetomidine dose on a mg basis). Provide supportive care: maintain airway, administer oxygen, intravenous fluids for hypotension, and atropine for severe bradycardia. Monitor vital signs closely. In severe cases, mechanical ventilation may be required.

Food Animal Withdrawal Times

🥩 Meat: 3 days🥛 Milk: 72 days

Withdrawal times are not officially established for all species; consult regulatory guidelines. For cattle, a meat withdrawal of 3 days and milk withdrawal of 72 hours is commonly recommended. For other food animals, follow label or veterinary direction.

Storage, Handling & Regulatory Information

Storage Temperature: Store at controlled room temperature 20-25°C (68-77°F), excursions permitted between 15-30°C (59-86°F)

Light Sensitivity: Light-sensitive — protect from direct exposure.

Handling & Special Conditions: Protect from light. Do not freeze. Keep container tightly closed.

Dispensing Status: Prescription Required (Rx Only)

Approval Status: Approved for use in dogs and cats (e.g., Dexdomitor®). Not approved for food animals in the US, but may be used extra-label.

Extra-Label (Off-Label) Use: In the US, dexmedetomidine is approved for use in dogs and cats. Extra-label use in other species is permitted under AMDUCA (Animal Medicinal Drug Use Clarification Act) with a valid veterinary-client-patient relationship. For food animals, observe withdrawal times and avoid residues.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Dexmedetomidine is a valuable agent for sedation and analgesia in veterinary practice. It provides reliable, reversible sedation with minimal respiratory depression when used at appropriate doses. It is often combined with opioids (e.g., butorphanol) or ketamine for enhanced analgesia and sedation. Reversal with atipamezole is rapid and complete, making it useful for outpatient procedures. However, its cardiovascular effects (bradycardia, hypotension) require careful patient selection and monitoring. In food animals, extra-label use requires attention to withdrawal times. Always have atipamezole available when using dexmedetomidine.

References & Literature

📚 Plumb's Veterinary Drug Handbook
📚 Papich Veterinary Pharmacology and Therapeutics
📚 Compendium of Veterinary Products (CVP)